Role of sclerostin in the bone and thyroid metabolism in patients with ovarian polycystic syndrome

Conclusions: Findings highlight that sclerostin is much raised in women with PCOS and could well be a useful biomarker of the syndrome's effects on bone and thyroid metabolism. Its moderate diagnostic performance however, further researches on its role in the pathophysiology of Polycystic Ovary Syndrome are needed.